CSIMarket
 


Aclaris Therapeutics Inc   (ACRS)
Other Ticker:  
 

Cumulative Aclaris Therapeutics Inc 's Quick Ratio for Trailing Twelve Months Period

ACRS's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

ACRS Quick Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Growth 6.64 % 3.75 % 15.31 % 54.17 % 39.5 %
Y / Y Cash & cash equivalent Growth 25.36 % 7.31 % 40.01 % 253.61 % 270.03 %
Quick Ratio for Trailing Twelve Months Period 11.7 11.2 11.06 10.67 9.85
Total Ranking # 267 # 379 # 420 # 458 # 369
Seq. Current Liabilities Growth 22.92 % -7.47 % -27.06 % 28.54 % 19.6 %
Seq. Cash & cash equivalent Growth -0.22 % 38.4 % -6.16 % -3.27 % -14.59 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Aclaris Therapeutics Inc Cash & cash equivalent average grew by 25.36 % in III. Quarter year on year, faster than Current Liabilities, this led to increase in in Aclaris Therapeutics Inc 's Quick Ratio for Trailing Twelve Months Period to 11.7, Quick Ratio for Trailing Twelve Months Period remained below Aclaris Therapeutics Inc average.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 117 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Aclaris Therapeutics Inc . While Quick Ratio for Trailing Twelve Months Period overall ranking has improved so far to 267, from total ranking in previous quarter at 379.

What is Quick Ratio?
Learn more about ACRS
Quick Ratio ACRS in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 118
Sector # 179
S&P 500 # 267


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
11.47 5.89 1.62
(Sep 30 2022)   (Jun 30 2020)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Eqrx Inc   31.28 
Stoke Therapeutics Inc   30.70 
Rezolute Inc   30.10 
Nanoviricides inc   29.85 
Day One Biopharmaceuticals Inc   29.51 
Immix Biopharma Inc   29.01 
Nuvalent Inc   28.15 
Synaptogenix Inc   27.97 
Diamedica Therapeutics Inc   27.74 
Kezar Life Sciences Inc   27.63 
Xortx Therapeutics Inc   26.89 
Edgewise Therapeutics inc.  26.69 
Janux Therapeutics Inc   26.66 
Spruce Biosciences Inc   26.18 
Pmv Pharmaceuticals Inc   26.04 
Immuneering Corp  25.90 
Merrimack Pharmaceuticals Inc  25.87 
Karuna Therapeutics Inc   25.77 
Dice Therapeutics Inc   25.43 
Gemini Therapeutics Inc   25.42 
Olema Pharmaceuticals inc   24.70 
Anaptysbio inc  24.68 
Cyteir Therapeutics Inc   24.17 
Silverback Therapeutics Inc   23.90 
Cassava Sciences Inc   23.60 
Kura Oncology Inc   23.54 
Imago Biosciences Inc   23.46 
Sensei Biotherapeutics Inc   23.27 
Astria Therapeutics inc   23.05 
Anixa Biosciences Inc   22.52 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MELI's Profile

Stock Price

MELI's Financials

Business Description

Fundamentals

Charts & Quotes

MELI's News

Suppliers

MELI's Competitors

Customers & Markets

Economic Indicators

MELI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071